​Mass production of placenta stem cells gets FDA approval

​Mass production of placenta stem cells gets FDA approval

The US Food and Drug Administration has granted approval to Pluristem Therapeutics to mass produce therapeutic human-placenta-derived stem cell products within its commercial-scale manufacturing facility in Haifa, Israel. Pluristem's Placental Expanded 

10
Like
Save

Comments

Write a comment

*